Deficiency in Nucleotide Excision Repair Family Gene Activity, Especially ERCC3, Is Associated with Non-Pigmented Hair Fiber Growth

por Yu, Mei, Bell, Robert H., Ho, Maggie M., Leung, Gigi, Haegert, Anne, Carr, Nicholas, Shapiro, Jerry, McElwee, Kevin J.
Publicado 2012

Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis

por Shi, Feng-Tao, Yu, Mei, Zloty, David, Bell, Robert H., Wang, Eddy, Akhoundsadegh, Noushin, Leung, Gigi, Haegert, Anne, Carr, Nicholas, Shapiro, Jerry, McElwee, Kevin J.
Publicado 2017

Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma

por D’Costa, Ninadh M., Cina, Davide, Shrestha, Raunak, Bell, Robert H., Lin, Yen-Yi, Asghari, Hossein, Monjaras-Avila, Cesar U., Kollmannsberger, Christian, Hach, Faraz, Chavez-Munoz, Claudia I., So, Alan I.
Publicado 2020

Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer

por Choi, Stephen Yiu Chuen, Ettinger, Susan L., Lin, Dong, Xue, Hui, Ci, Xinpei, Nabavi, Noushin, Bell, Robert H., Mo, Fan, Gout, Peter W., Fleshner, Neil E., Gleave, Martin E., Collins, Colin C., Wang, Yuzhuo
Publicado 2018

The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells

por Labrecque, Mark P., Takhar, Mandeep K., Nason, Rebecca, Santacruz, Stephanie, Tam, Kevin J., Massah, Shabnam, Haegert, Anne, Bell, Robert H., Altamirano-Dimas, Manuel, Collins, Colin C., Lee, Frank J.S., Prefontaine, Gratien G., Cox, Michael E., Beischlag, Timothy V.
Publicado 2016

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

por Lin, Dong, Ettinger, Susan L., Qu, Sifeng, Xue, Hui, Nabavi, Noushin, Chuen Choi, Stephen Yiu, Bell, Robert H., Mo, Fan, Haegert, Anne M., Gout, Peter W., Fleshner, Neil, Gleave, Martin E., Pollak, Michael, Collins, Colin C., Wang, Yuzhuo
Publicado 2017

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer

por Lin, Dong, Dong, Xin, Wang, Kendric, Wyatt, Alexander W., Crea, Francesco, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Bell, Robert H., Haegert, Anne, Brahmbhatt, Sonal, Hurtado-Coll, Antonio, Gout, Peter W., Fazli, Ladan, Gleave, Martin E., Collins, Colin C., Wang, Yuzhuo
Publicado 2014

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer

por Wyatt, Alexander W, Mo, Fan, Wang, Kendric, McConeghy, Brian, Brahmbhatt, Sonal, Jong, Lina, Mitchell, Devon M, Johnston, Rebecca L, Haegert, Anne, Li, Estelle, Liew, Janet, Yeung, Jake, Shrestha, Raunak, Lapuk, Anna V, McPherson, Andrew, Shukin, Robert, Bell, Robert H, Anderson, Shawn, Bishop, Jennifer, Hurtado-Coll, Antonio, Xiao, Hong, Chinnaiyan, Arul M, Mehra, Rohit, Lin, Dong, Wang, Yuzhuo, Fazli, Ladan, Gleave, Martin E, Volik, Stanislav V, Collins, Colin C
Publicado 2014

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma

por Shrestha, Raunak, Nabavi, Noushin, Lin, Yen-Yi, Mo, Fan, Anderson, Shawn, Volik, Stanislav, Adomat, Hans H., Lin, Dong, Xue, Hui, Dong, Xin, Shukin, Robert, Bell, Robert H., McConeghy, Brian, Haegert, Anne, Brahmbhatt, Sonal, Li, Estelle, Oo, Htoo Zarni, Hurtado-Coll, Antonio, Fazli, Ladan, Zhou, Joshua, McConnell, Yarrow, McCart, Andrea, Lowy, Andrew, Morin, Gregg B., Chen, Tianhui, Daugaard, Mads, Sahinalp, S. Cenk, Hach, Faraz, Le Bihan, Stephane, Gleave, Martin E., Wang, Yuzhuo, Churg, Andrew, Collins, Colin C.
Publicado 2019